These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 13713336

  • 1. [On changes in the iron level and serum protein fractions after cytostatic therapy with N-oxide mustard gas and a nitrogen mustard phosphamide ester].
    HENNE HF.
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1961; 297():128-38. PubMed ID: 13713336
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical results obtained with the use of a phosphamide ester of nitrogen mustard: Endoxan Asta].
    TERRASSE J, MARCHEIX J.
    Gaz Med Fr; 1961 Sep 25; 68():2079-82. PubMed ID: 13920355
    [No Abstract] [Full Text] [Related]

  • 4. [On the antineoplastic action of a cyclic phosphamide ester of nitrogen mustard (endoxan, or B 518). Clinical tests].
    DI PIETRO S.
    Minerva Med; 1959 Oct 27; 50():3450-4. PubMed ID: 13816482
    [No Abstract] [Full Text] [Related]

  • 5. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard.
    GOLD GL, SALVIN LG, SHNIDER BI.
    Cancer Chemother Rep; 1962 Feb 27; 16():417-9. PubMed ID: 13899670
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical experiences with rest nitrogen phosphamide esters in hemopathies].
    BRICHTA G, KUHBOCK J, REIMER EE.
    Wien Z Inn Med; 1958 Jul 27; 39(7):306-11. PubMed ID: 13604281
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of nitrogen mustard gas and colchicine on serum proteins].
    SCHOLTISSEK C.
    Z Krebsforsch; 1956 Jul 27; 61(4):390-5. PubMed ID: 13402006
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Hydrolysis of hexacyclic N-Lost phosphamide ester in buffered system].
    ARNOLD H, KLOSE H.
    Arzneimittelforschung; 1960 Apr 27; 10():288-91. PubMed ID: 13794369
    [No Abstract] [Full Text] [Related]

  • 14. Chemotherapeutic action of a cyclic nitrogen mustard phosphamide ester (B 518-ASTA) in experimental tumours of the rat.
    ARNOLD H, BOURSEAUX F, BROCK N.
    Nature; 1958 Mar 29; 181(4613):931. PubMed ID: 13526741
    [No Abstract] [Full Text] [Related]

  • 15. [A contribution to the chemotherapy of cancer with N-oxide-mustard].
    HAMMER O, TAUTENHAHN B.
    Med Nov; 1959 Aug 29; 35():1562-6. PubMed ID: 14399321
    [No Abstract] [Full Text] [Related]

  • 16. [2-Year results of cytostatic follow-up treatment of bronchial carcinoma].
    HENNE HF.
    Med Klin; 1960 May 20; 55():934-6. PubMed ID: 14401046
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparative investigation of the chemotherapeutic action of N-oxide-mustard gas and other alkylating compounds in rat tumors].
    DANNEBERG P, DRUCKREY H, KAISER K, LO HW, MECKE R, NIEPER HA, SCHMAHL D.
    Arzneimittelforschung; 1956 Sep 20; 6(9):539-50. PubMed ID: 13373668
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prolonged intravenous infusion chemotherapy of advanced cancer. I. Combined therapy with introgen mustard plus actinomycin D, thioTEPA plus actinomycin D, and thioTEPA plus actinomycin P2.
    LEONE LA, COLBERT MP, YORK CL.
    Cancer Chemother Rep; 1961 Dec 20; 15():21-32. PubMed ID: 14464104
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.